Burns Matteson Capital Management LLC Makes New $584,000 Investment in Cencora, Inc. $COR

Burns Matteson Capital Management LLC purchased a new position in Cencora, Inc. (NYSE:COR) during the fourth quarter, Holdings Channel reports. The fund purchased 1,730 shares of the company’s stock, valued at approximately $584,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in COR. United Bank raised its position in Cencora by 4.5% during the second quarter. United Bank now owns 7,032 shares of the company’s stock valued at $2,109,000 after purchasing an additional 305 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Cencora by 8.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 15,861 shares of the company’s stock worth $4,756,000 after purchasing an additional 1,184 shares in the last quarter. Quadrature Capital Ltd purchased a new position in shares of Cencora in the 2nd quarter worth about $241,000. Lido Advisors LLC increased its position in shares of Cencora by 23.0% during the 2nd quarter. Lido Advisors LLC now owns 7,956 shares of the company’s stock valued at $2,386,000 after purchasing an additional 1,487 shares during the last quarter. Finally, Edgestream Partners L.P. raised its holdings in shares of Cencora by 1,348.2% during the 2nd quarter. Edgestream Partners L.P. now owns 12,237 shares of the company’s stock valued at $3,669,000 after buying an additional 11,392 shares in the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Cencora Price Performance

COR opened at $313.88 on Wednesday. The stock’s 50 day simple moving average is $350.42 and its 200 day simple moving average is $341.25. The company has a debt-to-equity ratio of 3.62, a current ratio of 0.92 and a quick ratio of 0.51. Cencora, Inc. has a 1 year low of $267.40 and a 1 year high of $377.54. The firm has a market cap of $61.06 billion, a price-to-earnings ratio of 37.73, a PEG ratio of 1.44 and a beta of 0.68.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating the consensus estimate of $4.04 by $0.04. The firm had revenue of $85.93 billion during the quarter, compared to the consensus estimate of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The business’s revenue was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.73 earnings per share. As a group, analysts predict that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Friday, February 13th. Cencora’s dividend payout ratio is currently 28.85%.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Leerink Partners restated an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Wells Fargo & Company increased their price target on shares of Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. JPMorgan Chase & Co. boosted their price objective on shares of Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Barclays upped their price objective on shares of Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Finally, Morgan Stanley set a $380.00 target price on shares of Cencora in a report on Tuesday, March 17th. Twelve equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $403.17.

Insiders Place Their Bets

In other Cencora news, CEO Robert P. Mauch sold 5,096 shares of the stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the sale, the chief executive officer owned 66,726 shares of the company’s stock, valued at $23,669,713.98. This represents a 7.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.38% of the stock is owned by insiders.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.